A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Bryan Lanning(Scripps Research Institute), Landon R. Whitby(Scripps Research Institute), Melissa M. Dix(Scripps Research Institute), John Douhan(Pfizer (United States)), A. Gilbert(Pfizer (United States)), Erik C. Hett(Pfizer (United States)), Theodore Johnson(Pfizer (United States)), Chris Joslyn(Scripps Research Institute), John C. Kath(Pfizer (United States)), Sherry Niessen(Pfizer (United States)), Lee R. Roberts(Pfizer (United States)), Mark E. Schnute(Pfizer (United States)), Chu Wang(Scripps Research Institute), Jonathan J. Hulce(Scripps Research Institute), Baoxian Wei(Pfizer (United States)), Laurence O. Whiteley(Pfizer (United States)), Matthew M. Hayward(Pfizer (United States)), Benjamin F. Cravatt(Scripps Research Institute)
Cited by 362Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis